Stem Cells & Perinatal Therapies
Cell and perinatal products: promise, evidence, quality and clinical limitations.
RheumaView · Cellular therapy
CAR-T in rheumatology
A new ambition for autoimmune disease: lasting control after a finite treatment course.
Explore the mechanism →
Disease-specific evidence, safety and referral decisions.
Open the professional reading room →Watch. Explore. Decide.
CASCADE brings the cellular story and clinical reasoning into an interactive learning space.
CAR-T, seen in motion
From T-cell collection to receptor design and recognition of a CD19-positive B cell.
Watch the film →AnnaMaria · Explore CD19
Follow the animated mechanism, a fictional lupus-nephritis case and a simulated-data exercise.
Start the activity →Carmen · Weigh the choices
Choose patient priorities, evaluate the medical facts and compare your reasoning with the scenario.
Start the activity →The professional activities use fictional cases. Simulated results and scenario answer keys are clearly distinguished from clinical evidence.
The collection, at a glance.
Choose a chapter or search the complete text.
The idea & the biology
Mechanism, targets and cell platforms.
More in this section · 1
Evidence by disease
Read the diagnosis, design and denominator.
Clinical decisions
From referral to treatment and comparison.
More in this section · 1
Safety & follow-up
Acute toxicity, recovery and durability.
The next generation
Donor cells, RNA and in vivo approaches.
Research & practical resources
Trials, consultation tools and original sources.
More in this section · 4
Find the disease.
Direct routes into the evidence.
Keep disease control, medication withdrawal, immune recovery and reversal of damage separate. How to read the outcomes →
The September 2026 rap-cel and zola-cel disclosures concern distinct programs. Read the safety context →